These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6347)

  • 1. Influence of the properties of skin allografts on the "graft survival promoting effect" of antilymphocyte serum.
    Nouza K; Nêmec M; Viklický V; Novotný J
    Folia Biol (Praha); 1976; 22(2):74-81. PubMed ID: 6347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of phytohemagglutinin and antilymphocyte serum on the survival time of homologous skin grafts in mice].
    Kaden J; Kaden K
    Z Exp Chir; 1973; 6(6):401-9. PubMed ID: 4152194
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of tolerance of the Ia antigen disparate skin allografts.
    Holán V; Hasek M; Chutná J; Holoubková I
    Folia Biol (Praha); 1982; 28(6):395-408. PubMed ID: 6761152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of antilymphocyte serum on the antigen-binding cells of the blood and the survival of skin grafts].
    Dinoeva S
    Eksp Med Morfol; 1976; 15(2):89-95. PubMed ID: 776589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of allograft and xenograft survival by pretreatment with prednisolone and donor-specific antigen.
    Lie TS
    Surg Gynecol Obstet; 1976 Sep; 143(3):369-75. PubMed ID: 60786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of suppressor cell mechanism in antilymphocyte serum-induced skin allograft tolerance in mice.
    Rieger M; Hilgert I; Kristofová H; Vlachov K
    Folia Biol (Praha); 1979; 25(4):220-30. PubMed ID: 159195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strength of H-2 and non-H-2 antigens as compared in ALS-suppressed recipients.
    Hilgert I; Nouza K
    Folia Biol (Praha); 1970; 16(6):369-73. PubMed ID: 4394676
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of cyclophosphamide on the splecific unresponsiveness to skin allografts induced in ALS-treated mice infused with donor bone marrow.
    Wood ML; Monaco AP
    J Immunol; 1977 Apr; 118(4):1456-9. PubMed ID: 321691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged survival of skin allografts in rats treated with antigen and hydrocortisone and the trend in graft-versus-host reactions.
    Chutná J; Hasek M
    Folia Biol (Praha); 1975; 21(4):219-27. PubMed ID: 241669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditioning recipients of hemopoietic cells with antilymphocytic serum (ALS) and partial-body irradiation.
    Kolb H; Thierfelder S; Baumann P; Balk O
    Rev Eur Etud Clin Biol; 1971 Oct; 16(8):810-4. PubMed ID: 4399647
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolongation of the survival of skin allografts by the injection of spleen cells in adult mice treated by antilymphocyte serum.
    Brochier J; Fries D
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):303-7. PubMed ID: 4559763
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of skin grafts across the MSA-barrier in mice pretreated with sera from specifically or syngeeically grafted donors.
    Viklický V; Rossowski W; Polácková M; Skajster J
    Folia Biol (Praha); 1975; 21(6):375-81. PubMed ID: 1295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models of specific unresponsiveness to tissue allografts in antilymphocyte serum (ALS) treated mice.
    Wood ML; Monaco AP
    Transplant Proc; 1978 Jun; 10(2):379-87. PubMed ID: 354127
    [No Abstract]   [Full Text] [Related]  

  • 14. Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cells.
    Nakao A; Nalesnik MA; Ishikawa T; Azhipa O; Demetris AJ; Murase N
    Transplantation; 2003 May; 75(9):1575-81. PubMed ID: 12792518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
    Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
    J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of immunosuppressive agents and matching on pulmonary allografts.
    Motlagh FA; Dutta SK; Paley N; Karlson KE; Garzon AA
    Surg Forum; 1970; 21():196-8. PubMed ID: 4936968
    [No Abstract]   [Full Text] [Related]  

  • 17. Rat heart allograft survival with donor pretreatment.
    Freeman JS; Chamberlain E; Reemtsma K; Steinmuller D
    Circulation; 1971 May; 43(5 Suppl):I120-3. PubMed ID: 4931286
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific unresponsiveness to skin allografts in mice. IV. Immunological reactivity of mice treated with liver extracts, Bordetella pertussis, and antilymphocyte serum.
    Brooks CG; Brent L; Kilshaw PJ; New RR; Pinto M
    Transplantation; 1975 Feb; 19(2):134-44. PubMed ID: 235163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment with antilymphocyte globulin and donor cells on graft prolongation in an experimental model and some observations on graft-versus-host reaction.
    Pegrum GD; Williams G; Markwick J; Barnes RM
    Postgrad Med J; 1976; 52(5 Suppl):47-50. PubMed ID: 11454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependence of ALS effects on immunological and haematopoietic activities in mice.
    Nouza K; Haskovcová H; Nĕmec M
    Folia Biol (Praha); 1971; 17(5):312-21. PubMed ID: 4399318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.